Table 1.

Summary of in vivo results.

Group	Dosea	Incidence of diseaseb	Mean maximal score ± SEMc
PBS	100 µl/mouse on days −11, −8, and −5	12/12	2.30 ± 0.43
PLP	100 nmol/mouse on days −11, −8, and −5	12/12	1.50 ± 0.31
PLP-BPI	100 nmol/mouse on days −11, −8, and −5	1/12	0.08 ± 0.08

^aAll injections were administered subcateneously.

^bIncidence of disease was defined as a disease score of 1 or higher.

^cMean maximal disease scores were expressed as mean ± SEM (n = 12).